Radnostix INIS
OTC INIS
$0.05 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Radnostix (INIS) EV to EBIT (2012 - 2025)

Updated

Radnostix's (INIS) EV to EBIT was 159.41 for Q2 2025, up 34.4% from the prior quarter.

Analysis

Radnostix (INIS) EV to EBIT (2012 - 2025) Analysis & Trends

Over the twelve months ended Jun 30, 2025, Radnostix's EV to EBIT came in at 135.87; for FY2024, it came in at 1994.07.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Radnostix 23.81 Mn 17.92 Mn 1.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 159.41
Mar 31, 2025 118.58
Dec 31, 2024 1,994.07
Sep 30, 2012 123.44
API Access

Radnostix EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=INIS&period=max&api_key=YOUR_API_KEY